TUMOVCA

Inclusiecriteria: Je mag meedoen als

• Diagnosed with or suspected of ovarian cancer (primary or recurrent disease)
• Scheduled for diagnostic of palliative drainage of ascites or primary debulking surgery
• In case of ascites collection: Expected drainage > 250 ml in order to expect sufficient ‘left over ascites’
• Measurable disease on CT scans (according to RECIST1.1 criteria as defined by the GCIG )
• Possible candidate for systemic treatment with (neo-)adjuvant chemotherapy (according to judgment of treating physician) or scheduled for second, third or later lines of systemic therapy because of recurrent disease
• Age >18
• Written informed consent

Exclusiecriteria: Je mag niet meedoen als

• Absence of sufficient clinical data
• Absence of viable tumor tissue (ascites, or resected tumor tissue)
• Other histology than EOC

Het getoonde overzicht van studielocaties is (nog) niet compleet. Check met uw arts of deze studie ook nog ergens anders loopt.

• Alrijne Ziekenhuis
• Haaglanden Medisch Centrum
• Ziekenhuis Nij Smellinghe
• Tjongerschans Ziekenhuis
• Elkerliek Ziekenhuis